Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Operating Expenses: 2023-2024

Historic Operating Expenses for Pyxis Oncology (PYXS) over the last 2 years, with Dec 2024 value amounting to $105.6 million.

  • Pyxis Oncology's Operating Expenses fell 1.23% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.0 million, marking a year-over-year change of. This contributed to the annual value of $105.6 million for FY2024, which is 28.48% up from last year.
  • Pyxis Oncology's Operating Expenses amounted to $105.6 million in FY2024, which was up 28.48% from $82.2 million recorded in FY2023.
  • Pyxis Oncology's 5-year Operating Expenses high stood at $105.6 million for FY2024, and its period low was $82.2 million during FY2023.
  • Moreover, its 2-year median value for Operating Expenses was $93.9 million (2023), whereas its average is $93.9 million.
  • Data for Pyxis Oncology's Operating Expenses shows a peak YoY climbed of 28.48% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Pyxis Oncology's Operating Expenses stood at $82.2 million in 2023, then climbed by 28.48% to $105.6 million in 2024.